In 2011, Bayer received FDA approval for Eylea, an eye medicine for the treatment of wet age-related macular degeneration. In 2012, sales of Bayer Healthcare totalled €18 billion, with an ...

As our faculty, staff and students work together for structural change and an end to racial injustice, we’ve asked some members of the College of Medicine’s community to share what the Black Lives ...

Bayer will provide a minimum of $300 million in R&D investments to the JV over the next five years, and will acquire a minority stake in CRISPR Therapeutics for $35 million in cash.

Valvular heart disease (VHD) is a major focus of cardiovascular medicine, but limited data are available for racial and ethnic ... Stratified by race and ethnicity, 38.0%, 23.2%, 2.1%, and 36.7% were ...

Bayer AG (Leverkusen, Germany) and Neste Corp. (Espoo, Finland) announced that they have signed a memorandum of understanding (MOU) to jointly scale winter canola as a biomass-based feedstock for ...

In a bold move to restore $540 million in cost savings, Bayer CEO Bill Anderson cut out most of the company’s management roles last year. Since taking the helm in 2023, Anderson’s maneuvers ...

Bayer’s hot flash drug candidate has hit the mark in a phase 3 breast cancer trial, potentially positioning the German drugmaker to get the jump on Astellas’ rival drug Veozah. Astellas won ...

In a significant legal ruling, Bayer AG has been ordered by a Washington state jury to pay $100 million to four individuals who claim they suffered health issues due to exposure to polychlorinated ...

Neste and Bayer have signed a memorandum of understanding aimed at developing a winter canola ecosystem in the US. This includes identifying partners and developing the value chain together and ...

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane ...

Roche sees high single-digit core profit growth in 2025 A Washington jury on Tuesday ordered Bayer to pay $100 million to four people who say they were sickened by toxic chemicals known as PCBs at ...